rs754609693
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The ENST00000368547.4(ECHS1):c.541C>T(p.Arg181Cys) variant causes a missense change. The variant allele was found at a frequency of 0.00000682 in 1,612,354 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R181H) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000368547.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ECHS1 | NM_004092.4 | c.541C>T | p.Arg181Cys | missense_variant | 5/8 | ENST00000368547.4 | NP_004083.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ECHS1 | ENST00000368547.4 | c.541C>T | p.Arg181Cys | missense_variant | 5/8 | 1 | NM_004092.4 | ENSP00000357535 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152258Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 249306Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135232
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1460096Hom.: 0 Cov.: 34 AF XY: 0.00000826 AC XY: 6AN XY: 726392
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152258Hom.: 0 Cov.: 31 AF XY: 0.0000134 AC XY: 1AN XY: 74388
ClinVar
Submissions by phenotype
Mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | May 05, 2017 | The NM_004092.3(ECHS1):c.541C>T missense variant is in exon 5 of the ECHS1 gene (chr10:135180471). This substitution is predicted to create a change of an arginine to a cysteine at amino acid position 181, NP_004083.3(ECHS1):p.(Arg181Cys), which is considered significant. The arginine at this position has high conservation and therefore Grantham assessment (A-GVGD) is likely pathogenic. In silico software predicts this variant to be disease causing. It is situated within a known functional region (conserved trimeric quaternary structure which contains the catalytic core). This variant has not been previously observed in our patient cohort and has not been previously reported, but it has been observed in a population database at a frequency of 0.001% (ExAC). The variant is present in trans with a likely pathogenic ECHS1 variant, and additional biochemical evaluation is consistent with ECHS1 deficiency. Based on current information and biochemical evidence, this variant has been classified as LIKELY PATHOGENIC. - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2024 | ECHS1: PM2, PM3, PM5, PP3 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at